MIND Prize
The MIND Prize from Pershing Square Philanthropies funds innovative research to advance understanding and treatment of neurodegenerative diseases.
Funder: Pershing Square Philanthropies
Due Dates: September 29, 2025: Letter of Intent deadline | September 21, 2026: Letter of Intent deadline
Funding Amounts: $750,000 total ($250,000/year for 3 years, including up to 10% indirect costs); at least six awards annually
Summary: Supports bold, high-risk research by early-to-mid-career investigators to advance understanding and treatment of neurodegenerative diseases.
Key Information: Applicants may only apply three times total; only one LOI per PI per cycle.
Description
The MIND Prize, offered by Pershing Square Philanthropies, aims to accelerate transformative research in neurodegenerative diseases by supporting early-to-mid-career investigators who propose innovative, high-risk, high-reward projects. The program encourages interdisciplinary approaches and challenges conventional paradigms in neuroscience, with a focus on neurobiology, brain imaging, machine learning, drug delivery, synthetic biology, and related fields. The ultimate goal is to advance fundamental understanding and develop new strategies for predicting, preventing, and treating conditions such as Alzheimer’s Disease and Dementia. Awardees join a network of leading researchers and benefit from collaborative opportunities, networking events, and annual retreats.
